{"id":"euthyrox","rwe":[],"tags":[],"safety":{"boxedWarnings":["WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including EUTHYROX, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for"],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Weight loss","drugRate":"","severity":"common","organSystem":""},{"effect":"Increased appetite","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Tremors","drugRate":"","severity":"common","organSystem":""},{"effect":"Nervousness","drugRate":"","severity":"common","organSystem":""},{"effect":"Irritability","drugRate":"","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Heat intolerance","drugRate":"","severity":"common","organSystem":""},{"effect":"Muscle weakness","drugRate":"","severity":"common","organSystem":""},{"effect":"Palpitations","drugRate":"","severity":"common","organSystem":""},{"effect":"Tachycardia","drugRate":"","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"","severity":"common","organSystem":""},{"effect":"Anxiety","drugRate":"","severity":"common","organSystem":""},{"effect":"Excessive sweating","drugRate":"","severity":"common","organSystem":""},{"effect":"Skin rash","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Menstrual irregularities","drugRate":"","severity":"common","organSystem":""},{"effect":"Dyspnea","drugRate":"","severity":"common","organSystem":""},{"effect":"Flushing","drugRate":"","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Myocardial infarction","drugRate":"","severity":"serious"},{"effect":"Arrhythmias","drugRate":"","severity":"serious"},{"effect":"Heart failure","drugRate":"","severity":"serious"},{"effect":"Cardiac arrest","drugRate":"","severity":"serious"},{"effect":"Angina","drugRate":"","severity":"serious"},{"effect":"Seizures","drugRate":"","severity":"serious"},{"effect":"Pseudotumor cerebri","drugRate":"","severity":"serious"},{"effect":"Slipped capital femoral epiphysis","drugRate":"","severity":"serious"},{"effect":"Craniosynostosis","drugRate":"","severity":"serious"},{"effect":"Angioedema","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1624","moleculeType":"Small molecule","molecularWeight":"776.87"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"bc3c6830-ba68-4ba3-9896-a12d0ad0b275","title":"EUTHYROX (LEVOTHYROXINE SODIUM) TABLET [PROVELL PHARMACEUTICALS, LLC]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T04:37:32.514Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[],"indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06731764","phase":"PHASE2, PHASE3","title":"Novel Approaches to the Treatment of Hypothyroidism","status":"RECRUITING","sponsor":"UConn Health","startDate":"2024-12-10","conditions":"Hypothyroidism","enrollment":90},{"nctId":"NCT06724224","phase":"","title":"Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2024-04-08","conditions":"Congenital Hypothyroidism","enrollment":120},{"nctId":"NCT07463222","phase":"","title":"Neuroendocrine Response in Pediatric Febrile Seizures","status":"NOT_YET_RECRUITING","sponsor":"Aydin Adnan Menderes University","startDate":"2026-03","conditions":"Febrile Convulsion, Neuroendocrine Stress Response, Fever","enrollment":120},{"nctId":"NCT07424183","phase":"PHASE2","title":"T4/T3 Therapy in Hypothyroidism","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-03","conditions":"Hypothyroidism Primary","enrollment":60},{"nctId":"NCT07421869","phase":"NA","title":"SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2024-06-12","conditions":"Hypothyroidism","enrollment":107},{"nctId":"NCT05526144","phase":"PHASE2","title":"Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-04-01","conditions":"Nonalcoholic Steatohepatitis, Liver Fibrosis","enrollment":128},{"nctId":"NCT06073665","phase":"PHASE4","title":"Dosing of LT4 in Older Individuals","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-01-31","conditions":"Hypothyroidism","enrollment":228},{"nctId":"NCT05712421","phase":"PHASE2","title":"A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism","status":"COMPLETED","sponsor":"Neuvosyn Laboratories, LLC","startDate":"2023-02-28","conditions":"Hypothyroidism","enrollment":303},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT06647602","phase":"","title":"Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy","status":"NOT_YET_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2026-09-01","conditions":"Differentiated Thyroid Cancer, Thyroid Cancer, Levothyroxine","enrollment":40},{"nctId":"NCT07393165","phase":"NA","title":"Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-05-24","conditions":"Levothyroxine, Cardiac Function, Children","enrollment":40},{"nctId":"NCT06790589","phase":"PHASE2","title":"COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-12","conditions":"Advanced Differentiated Thyroid Gland Carcinoma","enrollment":70},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT07380854","phase":"NA","title":"Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2022-02-27","conditions":"Subclinical Hypothyroidism","enrollment":338},{"nctId":"NCT01391962","phase":"PHASE2","title":"Sunitinib or Cediranib for Alveolar Soft Part Sarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-07-18","conditions":"Sarcoma, Alveolar Soft Part","enrollment":34},{"nctId":"NCT07346157","phase":"PHASE1, PHASE2","title":"Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-03-01","conditions":"Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent","enrollment":69},{"nctId":"NCT07257250","phase":"","title":"Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2019-01-01","conditions":"Subclinical Hypothyroidism, Infertility, Assisted Reproductive Technology","enrollment":900},{"nctId":"NCT07332273","phase":"PHASE3","title":"Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2025-11-05","conditions":"Obesity","enrollment":286},{"nctId":"NCT07323706","phase":"NA","title":"Ayurvedic Diet in Myxedema","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2024-10-01","conditions":"Hypothyroidism Primary","enrollment":88},{"nctId":"NCT06345339","phase":"PHASE2, PHASE3","title":"A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-04-26","conditions":"Hypothyroidism","enrollment":2800},{"nctId":"NCT04746313","phase":"","title":"Prevalence of Hyperprolactinemia in Systemic Scleroderma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2021-03-01","conditions":"Sclerosis, Systemic, Scleroderma, Hyperprolactinemia","enrollment":71},{"nctId":"NCT07239674","phase":"PHASE3","title":"Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-11-30","conditions":"Intermediate-to-High Risk Differentiated Thyroid Cancer","enrollment":646},{"nctId":"NCT05228184","phase":"PHASE4","title":"Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)","status":"TERMINATED","sponsor":"IBSA Institut Biochimique SA","startDate":"2022-01-21","conditions":"Congenital Hypothyroidism","enrollment":34},{"nctId":"NCT04115514","phase":"PHASE2","title":"Treatment of ARDS With Instilled T3","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2020-03-30","conditions":"ARDS, Human, Lung, Wet, Thyroid","enrollment":68},{"nctId":"NCT03617835","phase":"PHASE1","title":"A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-08-16","conditions":"Healthy","enrollment":48},{"nctId":"NCT04290663","phase":"PHASE3","title":"Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up","status":"RECRUITING","sponsor":"Centre Francois Baclesse","startDate":"2020-03-02","conditions":"Thyroid Cancer, Intermediate Risk","enrollment":476},{"nctId":"NCT07205042","phase":"NA","title":"Walking for Hypothyroidism Trial (WHT)","status":"NOT_YET_RECRUITING","sponsor":"University of Karachi","startDate":"2025-11-01","conditions":"Hypothyroidism","enrollment":120},{"nctId":"NCT06083636","phase":"","title":"Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-07-26","conditions":"Hypothyroidism","enrollment":500},{"nctId":"NCT06652113","phase":"NA","title":"Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-11-15","conditions":"Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies","enrollment":796},{"nctId":"NCT06455371","phase":"NA","title":"Patient-centered Dosage of Levothyroxine","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2024-12-20","conditions":"Hypothyroidism, Thyroid Cancer, Thyroid","enrollment":240},{"nctId":"NCT03667664","phase":"NA","title":"PREPA PREvention of Loss of Autonomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2018-07-10","conditions":"Mobility Limitation, Physical Activity","enrollment":530},{"nctId":"NCT03977207","phase":"NA","title":"A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2020-07-20","conditions":"Thyroid; Functional Disturbance, Hypothyroidism, Hemodialysis","enrollment":336},{"nctId":"NCT06864351","phase":"NA","title":"Prospective Evaluation of OptiThyDose","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2025-08-28","conditions":"Thyroid Diseases, Congenital Hypothyroidism, Graves Disease","enrollment":150},{"nctId":"NCT06041204","phase":"NA","title":"Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2021-05-06","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical Hypothyroidism, Female Infertility","enrollment":200},{"nctId":"NCT07133295","phase":"","title":"Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients","status":"COMPLETED","sponsor":"Sohag University","startDate":"2021-03-23","conditions":"Hypothyroidism","enrollment":160},{"nctId":"NCT06660823","phase":"PHASE3","title":"Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-30","conditions":"Cardiac Surgery Intensive Care Treatment, Delayed Recovery From Anaesthesia, Euthyroid Sick Syndrome","enrollment":70},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05823012","phase":"PHASE2","title":"Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism","status":"COMPLETED","sponsor":"Xeris Pharmaceuticals","startDate":"2023-05-15","conditions":"Hypothyroidism","enrollment":46},{"nctId":"NCT05384847","phase":"PHASE1, PHASE2","title":"Effects of Triiodothyronine (T3) in Ischemic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2022-12-02","conditions":"Heart Failure","enrollment":20},{"nctId":"NCT07011953","phase":"EARLY_PHASE1","title":"A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia","status":"NOT_YET_RECRUITING","sponsor":"Peking University","startDate":"2025-07-01","conditions":"Schizophrenia, Avolition","enrollment":90},{"nctId":"NCT06999278","phase":"PHASE3","title":"LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss","status":"NOT_YET_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2025-06-01","conditions":"Abortion, Habitual","enrollment":200},{"nctId":"NCT06983418","phase":"","title":"Euthyroid Sick Syndrome in Obesity Hypoventilation Syndrome","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-09-01","conditions":"Euthyroid Sick Syndrome, Obesity Hypoventilation Syndrome (OHS)","enrollment":49},{"nctId":"NCT06205303","phase":"NA","title":"Interventional Study to Improve Medication Adherence Using Patient Decision Aid","status":"RECRUITING","sponsor":"SingHealth Polyclinics","startDate":"2024-03-15","conditions":"Hypothyroidism","enrollment":236},{"nctId":"NCT06971965","phase":"NA","title":"Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2025-06-02","conditions":"Thyroid Cancer, Papillary Thyroid Carcinoma","enrollment":578},{"nctId":"NCT06154382","phase":"","title":"Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit","status":"RECRUITING","sponsor":"Meir Medical Center","startDate":"2024-06-01","conditions":"Thyroid; Functional Disturbance","enrollment":350},{"nctId":"NCT06428097","phase":"PHASE1","title":"Levothyroxine Supplementation for Heart Transplant Recipients","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-03-29","conditions":"Heart Transplant Failure, Heart Transplant Infection","enrollment":97},{"nctId":"NCT06867913","phase":"NA","title":"A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2024-05-15","conditions":"Autoimmune Thyroiditis","enrollment":40},{"nctId":"NCT06924242","phase":"","title":"Thyroid Cancer in Surgical Treated Multinodular Goiter","status":"COMPLETED","sponsor":"University of Foggia","startDate":"2018-01-01","conditions":"Goiter, Nodular, Total Thyroidectomy, Thyroid Cancer","enrollment":223},{"nctId":"NCT04202094","phase":"NA","title":"Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems","status":"ENROLLING_BY_INVITATION","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-09-08","conditions":"Childhood Cancer, Hematological Disorders","enrollment":50},{"nctId":"NCT06649318","phase":"","title":"Effect of Brain GABA Metabolite Amount to Propofol Utilisation Under TIVA in Hypothyroid Patient","status":"COMPLETED","sponsor":"Duzce University","startDate":"2023-06-23","conditions":"Hypothyroidism, Anesthesia, General, Propofol Dosage","enrollment":80},{"nctId":"NCT06276205","phase":"PHASE3","title":"Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2024-03-01","conditions":"Hypothyroidism Primary, Lipid Disorder, Dyslipidemias","enrollment":62},{"nctId":"NCT05682482","phase":"PHASE3","title":"LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.","status":"RECRUITING","sponsor":"M. Medici","startDate":"2022-10-07","conditions":"Autoimmune Hypothyroidism","enrollment":600},{"nctId":"NCT04111536","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-03-08","conditions":"Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome","enrollment":28},{"nctId":"NCT03289403","phase":"PHASE2","title":"The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis","status":"COMPLETED","sponsor":"Aljazeera Hospital","startDate":"2018-03-07","conditions":"Infertility, Autoimmune Thyroiditis","enrollment":194},{"nctId":"NCT04112316","phase":"PHASE1, PHASE2","title":"Developing Oral LT3 Therapy for Heart Failure - HFrEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-02-11","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Low T3 Syndrome","enrollment":28},{"nctId":"NCT06735040","phase":"NA","title":"Effect of Photobiomodulation Therapy in Patients With Hashimoto's Thyroiditis","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2021-01-28","conditions":"Hashimoto Thyroiditis, Thyroiditis","enrollment":60},{"nctId":"NCT04754607","phase":"NA","title":"Effects of Low-Level Laser Therapy on Oxidative Stress Levels","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2021-02-09","conditions":"Hashimoto Thyroiditis, Autoimmune Thyroiditis, Thyroiditis","enrollment":46},{"nctId":"NCT06726967","phase":"","title":"Vitamin D, Hashimato's Thyroiditis and Thyroid Functions","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2019-02-01","conditions":"Vitamin D, Thyroid Autoimmune Disease","enrollment":81180},{"nctId":"NCT06715176","phase":"","title":"TREM-1 Pathway in Predicting Treatment Outcomes in Periodontitis","status":"COMPLETED","sponsor":"Aydin Adnan Menderes University","startDate":"2016-12-19","conditions":"Periodontal Diseases","enrollment":123},{"nctId":"NCT03173521","phase":"PHASE1, PHASE2","title":"Gene Therapy in Patients With Mucopolysaccharidosis Disease","status":"COMPLETED","sponsor":"Fondazione Telethon","startDate":"2017-07-17","conditions":"Mucopolysaccharidosis Type VI","enrollment":9},{"nctId":"NCT03880578","phase":"","title":"Quality of Life After Interventional Thyroid Treatment","status":"COMPLETED","sponsor":"Klinikum Lüdenscheid","startDate":"2019-04-01","conditions":"Thyroid; Deficiency, Quality of Life","enrollment":101},{"nctId":"NCT06659484","phase":"","title":"Health Data from Well on My Legs Program","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2016-09-20","conditions":"Sarcopenia, Frailty, Physical Inactivity","enrollment":1600},{"nctId":"NCT06653907","phase":"PHASE4","title":"Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody","status":"NOT_YET_RECRUITING","sponsor":"Yang ZHANG","startDate":"2024-10-25","conditions":"Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes","enrollment":400},{"nctId":"NCT06641440","phase":"PHASE4","title":"Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test","status":"COMPLETED","sponsor":"Centre for Endocrinology and Reproductive Medicine, Italy","startDate":"2018-01-01","conditions":"Recurrent Pregnancy Loss, Not Pregnant, Recurrent Implantation Failure","enrollment":42},{"nctId":"NCT06625814","phase":"PHASE1","title":"A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-08","conditions":"Healthy","enrollment":28},{"nctId":"NCT05412979","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism","status":"COMPLETED","sponsor":"Sention Therapeutics, LLC","startDate":"2022-04-29","conditions":"Hypothyroidism","enrollment":490},{"nctId":"NCT05276856","phase":"","title":"Recovery Rate in Secondary Hypothyroidism","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2022-04-04","conditions":"Secondary Hypothyroidism","enrollment":90},{"nctId":"NCT05918497","phase":"","title":"Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-04-25","conditions":"Different Regimens in Treatment of Hypothyroidism During Fasting in Ramadan","enrollment":89},{"nctId":"NCT06547242","phase":"PHASE1","title":"Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration","status":"COMPLETED","sponsor":"Berlin-Chemie AG Menarini Group","startDate":"2021-10-22","conditions":"Healthy","enrollment":132},{"nctId":"NCT06373523","phase":"EARLY_PHASE1","title":"MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2024-09-01","conditions":"Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease","enrollment":60},{"nctId":"NCT06527859","phase":"","title":"Correlation Between Levothyroxine and Blood Th17/Treg in Pregnant Women With Normal-high TSH and Positive TPOAb","status":"TERMINATED","sponsor":"Third Affiliated Hospital of Zhengzhou University","startDate":"2022-04-06","conditions":"Pregnancy Related, Thyroid Stimulating; Hormone, C","enrollment":64},{"nctId":"NCT06480682","phase":"","title":"Relative Energy Deficiency in Sport and Dance","status":"NOT_YET_RECRUITING","sponsor":"University of Wolverhampton","startDate":"2024-09-10","conditions":"Relative Energy Deficiency in Sport, Bone Stress Reaction","enrollment":200},{"nctId":"NCT04782856","phase":"PHASE2","title":"Energy Metabolism in Thyroidectomized Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-10-28","conditions":"Thyroid Goiter, Hypothyroidism, Thyroid Cancer","enrollment":13},{"nctId":"NCT04124705","phase":"PHASE2","title":"A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-10-11","conditions":"Hypothyroidism, Thyroid Disease, Euthyroid","enrollment":284},{"nctId":"NCT06408909","phase":"NA","title":"Pharmacist Role in Thyroid Disorders","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2022-03-15","conditions":"Hypothyroidism, Hyperthyroidism, Thyroid Diseases","enrollment":44},{"nctId":"NCT00648557","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-01","conditions":"Healthy","enrollment":32},{"nctId":"NCT00648700","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT00648882","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2007-03","conditions":"Healthy","enrollment":33},{"nctId":"NCT00647855","phase":"PHASE1","title":"Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-05","conditions":"Healthy","enrollment":30},{"nctId":"NCT06353555","phase":"NA","title":"Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-10-11","conditions":"Intracerebral Hemorrhage, Low T3 Syndrome, Neurocritical Care","enrollment":100},{"nctId":"NCT02320669","phase":"PHASE3","title":"Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2014-11","conditions":"Congenital Heart Defects","enrollment":220},{"nctId":"NCT06346236","phase":"","title":"Neurodevelopmental Impact of Treatment in Hypothyroxinaemia of Prematurity.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2020-03-01","conditions":"Transient Hypothyroxinemia of Prematurity","enrollment":373},{"nctId":"NCT06151548","phase":"PHASE4","title":"Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism.","status":"UNKNOWN","sponsor":"Poznan University of Physical Education","startDate":"2024-03-23","conditions":"Red Blood Cell Disorder, Oxidative Stress, Iron Metabolism Disorders","enrollment":30},{"nctId":"NCT06271434","phase":"NA","title":"Effects of Krill Oil on Intestinal Integrity Markers in Elite Rowers.","status":"UNKNOWN","sponsor":"Poznan University of Physical Education","startDate":"2024-03-23","conditions":"Endothelial Dysfunction","enrollment":30},{"nctId":"NCT05080491","phase":"NA","title":"Thyroid Profile in Attention Deficit With Hyperactivity Disorder (ADHD)","status":"UNKNOWN","sponsor":"Fondation Lenval","startDate":"2023-11-21","conditions":"Attention Deficit With Hyperactivity Disorder","enrollment":400},{"nctId":"NCT02725879","phase":"","title":"FGF-21 Levels and RMR in Children and Adolescents With Hashimoto's Thyroiditis (THYROMETABOL)","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2015-10","conditions":"Hashimoto Disease","enrollment":90},{"nctId":"NCT05733078","phase":"PHASE2","title":"Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism","status":"UNKNOWN","sponsor":"Dr Adnan Agha","startDate":"2023-11-01","conditions":"Hypothyroidism, Primary Hypothyroidism, Vitamin C Deficiency","enrollment":40},{"nctId":"NCT04415658","phase":"PHASE3","title":"Intravenous Thyroxine for Heart-Eligible Organ Donors","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-12-01","conditions":"Brain Death, Heart Failure","enrollment":838},{"nctId":"NCT05461820","phase":"PHASE4","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-05-01","conditions":"Graves Disease, Relapse, Treatment","enrollment":240},{"nctId":"NCT05316922","phase":"PHASE3","title":"TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients","status":"RECRUITING","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2021-12-13","conditions":"Hypothyroidism; Irradiation","enrollment":68},{"nctId":"NCT06135948","phase":"PHASE4","title":"Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism","status":"COMPLETED","sponsor":"Emirates Health Services (EHS)","startDate":"2022-03-15","conditions":"L-thyroxine","enrollment":103},{"nctId":"NCT04288115","phase":"PHASE4","title":"Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-03-24","conditions":"Subclinical Hypothyroidism","enrollment":52},{"nctId":"NCT05182931","phase":"PHASE2","title":"A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)","status":"UNKNOWN","sponsor":"Olivia Newton-John Cancer Research Institute","startDate":"2022-07-14","conditions":"Thyroid Cancer","enrollment":80},{"nctId":"NCT04964284","phase":"PHASE3","title":"Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2021-10-06","conditions":"Differentiated Thyroid Cancer","enrollment":328},{"nctId":"NCT06087068","phase":"PHASE2","title":"Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-08-01","conditions":"Thyroid Cancer, Surgery, Recurrence","enrollment":140},{"nctId":"NCT05551455","phase":"NA","title":"Endocrinological and Physiological Responses to Short-term Reduced Carbohydrate Availability in Males","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2022-05-04","conditions":"Energy Supply; Deficiency, Carbohydrate Availability","enrollment":8},{"nctId":"NCT06033456","phase":"NA","title":"Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome","status":"UNKNOWN","sponsor":"National Cancer Institute, Egypt","startDate":"2023-10-07","conditions":"Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes","enrollment":150},{"nctId":"NCT05270798","phase":"PHASE2","title":"Thyroid Hormone Supplementation in Patients With Septic Shock","status":"COMPLETED","sponsor":"Cantonal Hospital Zenica","startDate":"2022-05-01","conditions":"Euthyroid Sick Syndromes, Septic Shock","enrollment":108},{"nctId":"NCT06036576","phase":"PHASE3","title":"Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2022-03-01","conditions":"Recurrent Early Pregnancy Loss, Thyroid Diseases","enrollment":77},{"nctId":"NCT04747275","phase":"PHASE4","title":"Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients","status":"TERMINATED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2021-01-18","conditions":"Hypothyroidism, Trisomy 21","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20220427","type":"SUPPL","sponsor":"EMD SERONO INC","applicationNumber":"NDA021292"},{"date":"20020531","type":"ORIG","sponsor":"EMD SERONO INC","applicationNumber":"NDA021292"},{"date":"20180914","type":"SUPPL","sponsor":"EMD SERONO INC","applicationNumber":"NDA021292"},{"date":"20180914","type":"SUPPL","sponsor":"EMD SERONO INC","applicationNumber":"NDA021292"},{"date":"20180914","type":"SUPPL","sponsor":"EMD SERONO INC","applicationNumber":"NDA021292"},{"date":"20090326","type":"SUPPL","sponsor":"EMD SERONO INC","applicationNumber":"NDA021292"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":46,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Euthyrox","genericName":"Euthyrox","companyName":"Peking Union Medical College Hospital","companyId":"peking-union-medical-college-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}